ALPHA COGNITION
Alpha Cognition is a clinical-stage, biopharmaceutical company developing treatments for under-served neurodegenerative diseases. It features ALPHA-1062, a patented new chemical entity that has demonstrated safety and improved tolerability in human clinical trials. It is being developed as a new acetylcholine esterase inhibitor for the treatment of dementia of Alzheimer’s type, with minimal gastrointestinal side effects and novel routes of administration.
ALPHA COGNITION
Industry:
Biopharma Health Care Medical Pharmaceutical
Founded:
2014-01-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.alphacognition.com
Total Employee:
1+
Status:
Active
Contact:
(604) 684-3323
Email Addresses:
[email protected]
Total Funding:
19.85 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Apple Mobile Web Clips Icon Google Tag Manager Google Analytics Content Delivery Network Font Awesome Global Site Tag Mobile Non Scaleable Content ReCAPTCHA
Similar Organizations
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
LivWell
LivWell is dispensary company that provides exceptional cannabis products.
LucasPye BIO
A Contract Development and Manufacturing Organization (CDMO) that manufactures protein-therapeutic and viral-therapeutic drug products.
Marius Pharmaceuticals
Marius Pharmaceuticals is a biopharmaceutical company that brings novel treatments to a range of diseases with unmet medical needs.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Osciflex
Osciflex system imitates nature’s process to prevent deadly blood clots.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Trevarx Biomedical
Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.
Current Employees Featured
Founder
Stock Details
Key Employee Changes
| Date | New article |
|---|---|
| 2021-12-02 | Alpha Cognition Appoints Cedric O’Gorman, M.D., MBA as Chief Medical Officer |
Official Site Inspections
http://www.alphacognition.com
- Host name: 205.189.117.51
- IP address: 205.189.117.51
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto
More informations about "Alpha Cognition"
Alpha Cognition Inc. - Building new Transformative Treatments for ...
Nov 12, 2024 · ALPHA COGNITION is a commercial stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, …See details»
About ACI - Alpha Cognition
Alpha Cognition is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer’s disease for which there are …See details»
Alpha Cognition Inc. - Building new Transformative Treatments for ...
Prior to that, Kurt served as Head of US Medical Affairs at Acacia Pharma, Inc., and built and led the Medical Affairs organization through the successful launch of two new products. On his …See details»
Alpha Cognition, Inc. | LinkedIn
Alpha Cognition is a clinical stage, biopharmaceutical company dedicated to developing novel treatments for under-served neurodegenerative diseases such as Alzheimer’s Dementia and …See details»
Alpha Cognition Announces First Quarter of 2024 Results and …
May 14, 2024 · VANCOUVER, British Columbia, May 14, 2024 -- (BUSINESS WIRE)-- Alpha Cognition Inc. (CSE: ACOG) (OTCQB: ACOGF) ("Alpha Cognition", or the "Company"), a …See details»
Alpha Cognition Announces Formation and Members of Scientific …
Oct 1, 2021 · “Collectively we will aim to guide Alpha Cognition through the development of its current pipeline and to provide the team at Alpha Cognition with real world perspective on the …See details»
Alpha Cognition Inc. (ACOG) Company Profile & Overview - Stock …
2 days ago · Alpha Cognition Inc., a clinical stage biopharmaceutical company, engages in the development of treatments for Alzheimer’s disease and amyotrophic lateral sclerosis (ALS). …See details»
Alpha Cognition Announces FDA Acceptance of New Drug
Dec 7, 2023 · Alpha Cognition Inc., a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, is pleased to announce that the U.S. Food and …See details»
Alpha Cognition Announces Positive Results from Pivotal Study …
Jun 22, 2022 · Alpha Cognition Inc. is a clinical stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as …See details»
Alpha Cognition Inc. - Building new Transformative Treatments for ...
Apr 30, 2021 · Alpha Cognition Inc. is a clinical stage, biopharmaceutical company dedicated to developing treatments for under-served neurodegenerative diseases, such as Alzheimer's …See details»
Alpha Cognition Announces Director Change and Stock Option …
Dec 27, 2021 · Alpha Cognition Inc. is a clinical stage, biopharmaceutical company dedicated to developing treatments for under-served neurodegenerative diseases, such as Alzheimer's …See details»
Alpha Cognition CNSX:ACOG Stock Report - Simply Wall St
3 days ago · Alpha Cognition Inc., a clinical stage biopharmaceutical company, engages in the development of treatments for Alzheimer’s disease and amyotrophic lateral sclerosis (ALS). …See details»
Alpha Cognition Inc. | The Canadian Securities Exchange (CSE)
Alpha Cognition Inc. is a pre-NDA, biopharmaceutical company dedicated to developing treatments for patients suffering from Alzheimer’s disease and ALS.See details»
AlphaCognition Company Profile - Office Locations, Competitors
AlphaCognition is a biopharmaceutical company developing therapies for brain and spinal cord diseases. It aims to find alternative ways of treating Alzheimer’s disease and Amyotrophic …See details»
Alpha Cognition Inc. - Building new Transformative Treatments for ...
VANCOUVER, British Columbia — November 12, 2024 (BUSINESS WIRE) — Alpha Cognition Inc. (Nasdaq: ACOG) (CSE: ACOG) (“Alpha Cognition”, or the “Company”), a …See details»
Alpha Cognition - Overview, News & Similar companies - ZoomInfo
Apr 3, 2024 · View Alpha Cognition (www.alphacognition.com) location in British Columbia, Canada , revenue, industry and description. Find related and similar companies as well as …See details»
Alpha Cognition Inc. (ACOG.CN) - Yahoo Finance Canada
Alpha Cognition Inc., a clinical stage biopharmaceutical company, engages in the development of treatments for Alzheimer's disease and amyotrophic lateral sclerosis (ALS). The company …See details»
Alpha Cognition Inc. - Building new Transformative Treatments for ...
Apr 28, 2022 · Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the …See details»
Alpha Cognition Announces the Acceptance of its US FDA …
Sep 7, 2021 · ALPHA-1062 is being developed as a new generation of acetylcholine esterase inhibitor (AChEI) designed to improve upon the existing standard of care by overcoming …See details»
Alpha Cognition Company Profile 2024: Stock Performance
Alpha Cognition Inc is a commercial-stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's …See details»